Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Image Competition 2023 Results, Part 3—People’s Choice Winner

Rajat Ranka, MD  |  Issue: February 2024  |  February 9, 2024

For the 2023 Image Competition, the ACR sought images representing a diverse range of patients with idiopathic inflammatory myopathies (IIMs) or IIM mimics.

Chronic Facial Ulcers in Anti-Melanoma-Differentiation-Associated Gene 5 (MDA-5) Antibody Amyopathic Dermatomyositis

These images depict a 27-year-old patient who developed erythematous violaceous lesions over his upper chest, face and scalp over six months. Such lesions are associated with photosensitivity, non-scarring alopecia, oral ulcers, heliotrope rash and Gottron papules. Progressive ulcers over the bilateral malar areas and the left angle of the mandible followed. Ulcer edge biopsy showed perivascular and peri-adnexal lymphoid infiltrates, vacuolar interface dermatitis and basement membrane zone thickening, with no clinical, radiological or laboratory evidence of myositis, interstitial lung disease or arthritis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The patient was positive for the anti-melanoma-differentiation-associated gene 5 (MDA-5) antibody and was diagnosed with amyopathic dermatomyositis. Anti-MDA-5 antibody is usually associated with digital and extensor ulcers; however, facial ulceration, as in this case, is rare.

Learn More

Anti-MDA-5 antibody positivity is associated with often severe and rapidly progressive interstitial lung disease (ILD). Thus, all patients with anti-MDA-5 antibody should be evaluated with pulmonary function testing and high-resolution computed tomography imaging of the chest. It’s important to carefully evaluate these patients for muscle involvement, which can be subtle.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

For more information, visit https://www.the-rheumatologist.org/article/a-world-of-difference-updates-from-the-global-rheumatology-summit, and review the section on IIMs.


Rajat Ranka, MD, is a senior resident in rheumatology and clinical immunology at All India Institute of

Medical Science, Rishikesh.

About the Contest

The Rheumatology Image Library is a highly accessed teaching resource and images from the ACR’s annual contest are added to it, keeping the library dynamic and current. In addition to the Best Overall Image in 2023, winning images were selected from four regions around the world. Look for the People’s Choice and regional winners in future issues and on our website.

Share: 

Filed under:ConditionsMyositis Tagged with:amyopathic dermatomyositisdermatomyositisimage case reportImage Competition

Related Articles
    Cancer-Associated Myositis: A Case Report & Review of the Literature

    Cancer-Associated Myositis: A Case Report & Review of the Literature

    February 17, 2019

    Since it was first reported in 1916, a correlation between inflammatory myopathies and cancer has been noted in several studies. Population studies have confirmed this relationship, and the phrase cancer-associated myopathy has entered the vernacular. Over the past decade, research efforts have shifted toward revealing associations between autoantibodies and clinical phenotypes. One subset of auto-antigens…

    Tashatuvango / shutterstock.com

    Myositis-Specific Antibodies Identified

    January 16, 2020

    The idiopathic inflammatory myopathies (IIM) encompass eight categories: 1) dermatomyositis (DM) in adults, 2) juvenile dermatomyositis, 3) amyopathic DM, 4) cancer-associated DM, 5) polymyositis, 6) immune-mediated necrotizing myopathy, 7) inclusion body myositis, and 8) overlap myositis.1 These categories help classify the myopathies based on clinical and histologic features. The incidence of IIM is estimated at…

    Case Report: Rapidly Progressive Interstitial Lung Disease in a 6-Year-Old

    April 17, 2021

    Clinically amyopathic dermatomyositis (CADM), a rare subset of dermatomyositis (DM), is an autoimmune disease characterized by cutaneous findings of typical DM without evidence of myositis. Childhood presentation of CADM is rare, and not many studies describe the epidemiology of juvenile CADM.1,2 Although lung disease is rare among patients with juvenile DM, a few reports have…

    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences